St. Jude/Cambridge Heart sales
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical will market Cambridge Heart's HearTwave II microvolt t-wave alternans test to North American primary care and internal medicine physicians under an amendment to the firms' three-year marketing agreement, they announce June 18. Under the original deal, signed in March, St. Jude was only to target electrophysiologists and cardiologists for sales of the product, which is used to stratify patients by risk for implantable defibrillator need (1"The Gray Sheet" March 26, 2007, p. 8). Cambridge Heart's reps, who originally addressed the primary care and internal medicine market, will now support St. Jude's team in all physician markets...